CSC HOLDINGS - CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ (1,538)	$ (25,198)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, Depletion and Amortization	547,569	561,428
Gain (Loss) on Investments And Sale Of Affiliated Interests	455,473	(254,725)
Loss (gain) on equity derivative contracts, net	(439,861)	177,029
Loss on extinguishment of debt and write-off of deferred financing costs	0	157,902
Amortization of deferred financing costs and discounts (premiums) on indebtedness	23,944	26,066
Share-based compensation expense related to equity classified awards	27,370	13,790
Deferred income taxes	30,225	(19,918)
Provision for doubtful accounts	19,880	15,091
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable, trade	(4,458)	28,278
Other receivables	(2,958)	(707)
Prepaid expenses and other assets	(31,842)	(19,840)
Amounts due from and due to affiliates	3,894	(4,023)
Accounts payable	23,613	33,889
Accrued liabilities	(188,765)	(239,562)
Deferred revenue	(5,153)	8,915
Liabilities related to interest rate swap contracts	122,849	25,120
Net cash provided by operating activities	593,565	503,994
Cash flows from investing activities:
Capital expenditures	(299,082)	(340,386)
Proceeds related to sale of equipment and costs of disposal	(2,580)	479
Decrease in other investments	4,008	0
Additions to other intangible assets	(89)	0
Net cash used in investing activities	(297,743)	(339,907)
Cash flows from financing activities:
Proceeds from credit facility debt, net of discounts	0	1,390,000
Repayment of credit facility debt	(10,688)	(361,250)
Proceeds from issuance of senior notes	0	1,754,375
Redemption of senior notes, including premiums and fees	0	(2,462,692)
Proceeds from Contributed Capital	2,032	0
Repayment of notes payable	(7,495)	(58,500)
Principal payments on finance lease obligations	(5,700)	(1,611)
Additions to deferred financing costs	0	(11,678)
Contingent payment for acquisition	(4,947)	(500)
Proceeds from (Payments to) Noncontrolling Interests	0	(1,000)
Net cash used in financing activities	(752,803)	(339,615)
Net decrease in cash and cash equivalents	(456,981)	(175,528)
Effect of exchange rate changes on cash and cash equivalents	(424)	(245)
Net decrease in cash and cash equivalents	(457,405)	(175,773)
Cash, cash equivalents and restricted cash at beginning of year	702,160	299,038
Cash, cash equivalents and restricted cash at end of period	244,755	123,265
Restructuring Reserve, Settled without Cash	1,347	8,583
Non-cash lease expense	11,474	11,705
CSC Holdings
Cash flows from operating activities:
Net income	10,122	(7,864)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, Depletion and Amortization	547,569	561,428
Gain (Loss) on Investments And Sale Of Affiliated Interests	455,819	(254,725)
Loss (gain) on equity derivative contracts, net	(439,861)	177,029
Loss on extinguishment of debt and write-off of deferred financing costs	0	157,902
Amortization of deferred financing costs and discounts (premiums) on indebtedness	23,944	21,579
Settlement loss and amortization of actuarial losses related to pension and postretirement plans	502	171
Share-based compensation expense related to equity classified awards	27,370	13,790
Deferred income taxes	172,835	(13,007)
Provision for doubtful accounts	19,880	15,091
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable, trade	(4,458)	28,278
Other receivables	(2,958)	(708)
Prepaid expenses and other assets	(31,842)	(19,839)
Amounts due from and due to affiliates	(147,183)	(14,712)
Accounts payable	23,613	33,889
Accrued liabilities	(188,760)	(240,722)
Deferred revenue	(5,153)	8,915
Liabilities related to interest rate swap contracts	122,849	25,120
Net cash provided by operating activities	597,109	511,903
Cash flows from investing activities:
Capital expenditures	(299,082)	(340,386)
Proceeds related to sale of equipment and costs of disposal	(2,580)	479
Additions to other intangible assets	(89)	0
Net cash used in investing activities	(301,751)	(339,907)
Cash flows from financing activities:
Proceeds from credit facility debt, net of discounts	0	1,390,000
Repayment of credit facility debt	(10,688)	(361,250)
Proceeds from issuance of senior notes	0	1,754,375
Redemption of senior notes, including premiums and fees	0	(2,462,692)
Payments of dividends	720,350	594,462
Repayment of notes payable	(7,495)	(58,500)
Principal payments on finance lease obligations	(5,700)	(1,611)
Additions to deferred financing costs	0	(11,678)
Contingent payment for acquisition	(4,947)	(500)
Proceeds from (Payments to) Noncontrolling Interests	0	(1,000)
Net cash used in financing activities	(749,180)	(347,318)
Net decrease in cash and cash equivalents	(453,822)	(175,322)
Effect of exchange rate changes on cash and cash equivalents	(424)	(245)
Net decrease in cash and cash equivalents	(454,246)	(175,567)
Cash, cash equivalents and restricted cash at beginning of year	698,003	298,784
Cash, cash equivalents and restricted cash at end of period	243,757	123,217
Restructuring Reserve, Settled without Cash	1,347	8,583
Non-cash lease expense	$ 11,474	$ 11,705